- Filed
- Apr 7, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Mar 30, 2021 | 5.76M sh |
| Capex | FY 2020 · Dec 31, 2019 | $9K |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | −$301K |
| Short Term Debt restated | FY 2020 · Dec 31, 2019 | $841K |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $25K |
| Cash And Equivalents | FY 2020 · Dec 31, 2018 | $335K |
| Current Liabilities | FY 2020 · Dec 31, 2019 | $4.67M |
| Total Liabilities restated | FY 2020 · Dec 31, 2019 | $5.56M |
| Current Assets | FY 2020 · Dec 31, 2019 | $108K |
| Total Assets | FY 2020 · Dec 31, 2019 | $121K |
| Sga Expense restated | FY 2020 · Dec 31, 2019 | $767K |
| Rd Expense | FY 2020 · Dec 31, 2019 | $630K |
| Net Income | FY 2020 · Dec 31, 2019 | −$1.09M |
| Operating Income restated | FY 2020 · Dec 31, 2019 | −$783K |
| Revenue | FY 2020 · Dec 31, 2019 | $844K |
| Stockholders Equity | FY 2020 · Dec 31, 2018 | −$4.61M |